The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunityChristina K. Baumgartner, Joshua H. Decker, Kira E. Olander et al.|Nature|2023Cited by 170
TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapyChirag H. Patel, Jonathan D. Powell|JCI Insight|2023Cited by 13